Report: Sword delivers 3:1 ROI on medical spend

June 10, 2024

Fully independent analysis confirms Sword delivers 3:1 ROI on medical spend.

  • The study reports the highest medical savings in the MSK market, setting a new benchmark for cost-effectiveness.
  • Performed by Risk Strategies Consulting, a recognized leader in actuarial and risk management consulting, known for rigorous and precise evaluations.
  • The only claims-based analysis for MSK savings conducted by a third-party firm

Read the report.

Get the latest news from Sword
Email is required

A life free of pain starts here.

Portugal 2020Norte 2020European UnionPlano de Recuperação e ResiliênciaRepública PortuguesaNext Generation EU